About ProChon Biotech
ProChon Biotech is a company based in Rehovot (Israel) founded in 1996 was acquired by Histogenics in May 2011.. ProChon Biotech operates in a competitive market with competitors including Horizon Therapeutics, Ensoma, Tenaya Therapeutics, Orca Bio and Athira Pharma, among others.
- Headquarter Rehovot, Israel
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$3.95 M (USD), Debt – Convertible
Jan 20, 2010
- Investors
-
Employee Count
Employee Count
-
Acquired by
Histogenics
(May 16, 2011)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ProChon Biotech
- Total Funding Total Funding
- Total Rounds 1
- Last Round Debt – Convertible — $4.0M
-
First Round
First Round
(20 Jan 2010)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2010 | Amount | Debt – Convertible - ProChon Biotech | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ProChon Biotech
ProChon Biotech has secured backing from 1 investor. Prominent investors backing the company include Histogenics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Restorative cell therapies for orthopedic diseases are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ProChon Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ProChon Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Prochon Biotech Comparisons
Competitors of ProChon Biotech
ProChon Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Horizon Therapeutics, Ensoma, Tenaya Therapeutics, Orca Bio and Athira Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
|
| domain | founded_year | HQ Location |
Provider of in vivo stem cell modification technologies and vector-based drug delivery tool
|
|
| domain | founded_year | HQ Location |
Regenerative and gene therapeutics for heart failure are developed.
|
|
| domain | founded_year | HQ Location |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapeutics, including for Alzheimer’s and Parkinson’s, are developed.
|
|
| domain | founded_year | HQ Location |
Restorative cell therapies for orthopedic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about ProChon Biotech
When was ProChon Biotech founded?
ProChon Biotech was founded in 1996 and raised its 1st funding round 14 years after it was founded.
Where is ProChon Biotech located?
ProChon Biotech is headquartered in Rehovot, Israel. It is registered at Rehovot, Central District, Israel.
What does ProChon Biotech do?
ProChon Biotech develops and commercializes regenerative biology-based products for acute and chronic articular cartilage focal lesions. The company focuses on modulating the fibroblast growth factor system to enable it to create solutions for tissue regeneration. It offers orthobiologic therapeutic solutions, including BioCart Autologous Cartilage Regeneration system, a solution for the restoration of articular cartilage lesions that results in the regeneration of hyaline-like tissue. It was acquired by Histogenics in May, 2011.
Who are the top competitors of ProChon Biotech?
ProChon Biotech's top competitors include Horizon Therapeutics, Tenaya Therapeutics and Athira Pharma.
Who are ProChon Biotech's investors?
ProChon Biotech has 1 investor. Key investors include Histogenics.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.